226 related articles for article (PubMed ID: 12118371)
1. Phosphorylation of human estrogen receptor alpha at serine 118 by two distinct signal transduction pathways revealed by phosphorylation-specific antisera.
Chen D; Washbrook E; Sarwar N; Bates GJ; Pace PE; Thirunuvakkarasu V; Taylor J; Epstein RJ; Fuller-Pace FV; Egly JM; Coombes RC; Ali S
Oncogene; 2002 Jul; 21(32):4921-31. PubMed ID: 12118371
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation at serines 104 and 106 by Erk1/2 MAPK is important for estrogen receptor-alpha activity.
Thomas RS; Sarwar N; Phoenix F; Coombes RC; Ali S
J Mol Endocrinol; 2008 Apr; 40(4):173-84. PubMed ID: 18372406
[TBL] [Abstract][Full Text] [Related]
3. Activation of estrogen receptor alpha by S118 phosphorylation involves a ligand-dependent interaction with TFIIH and participation of CDK7.
Chen D; Riedl T; Washbrook E; Pace PE; Coombes RC; Egly JM; Ali S
Mol Cell; 2000 Jul; 6(1):127-37. PubMed ID: 10949034
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of human estrogen receptor alpha by protein kinase A regulates dimerization.
Chen D; Pace PE; Coombes RC; Ali S
Mol Cell Biol; 1999 Feb; 19(2):1002-15. PubMed ID: 9891036
[TBL] [Abstract][Full Text] [Related]
5. Antagonist-induced, activation function-2-independent estrogen receptor alpha phosphorylation.
Lipfert L; Fisher JE; Wei N; Scafonas A; Su Q; Yudkovitz J; Chen F; Warrier S; Birzin ET; Kim S; Chen HY; Tan Q; Schmidt A; Dininno F; Rohrer SP; Hammond ML; Rodan GA; Freedman LP; Reszka AA
Mol Endocrinol; 2006 Mar; 20(3):516-33. PubMed ID: 16223974
[TBL] [Abstract][Full Text] [Related]
6. Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance.
Campbell RA; Bhat-Nakshatri P; Patel NM; Constantinidou D; Ali S; Nakshatri H
J Biol Chem; 2001 Mar; 276(13):9817-24. PubMed ID: 11139588
[TBL] [Abstract][Full Text] [Related]
7. A functional serine 118 phosphorylation site in estrogen receptor-alpha is required for down-regulation of gene expression by 17beta-estradiol and 4-hydroxytamoxifen.
Cheng J; Zhang C; Shapiro DJ
Endocrinology; 2007 Oct; 148(10):4634-41. PubMed ID: 17615152
[TBL] [Abstract][Full Text] [Related]
8. Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells.
Marsaud V; Gougelet A; Maillard S; Renoir JM
Mol Endocrinol; 2003 Oct; 17(10):2013-27. PubMed ID: 12855746
[TBL] [Abstract][Full Text] [Related]
9. Enhanced estrogen receptor (ER) alpha, ERBB2, and MAPK signal transduction pathways operate during the adaptation of MCF-7 cells to long term estrogen deprivation.
Martin LA; Farmer I; Johnston SR; Ali S; Marshall C; Dowsett M
J Biol Chem; 2003 Aug; 278(33):30458-68. PubMed ID: 12775708
[TBL] [Abstract][Full Text] [Related]
10. Regulation of estrogen receptor nuclear export by ligand-induced and p38-mediated receptor phosphorylation.
Lee H; Bai W
Mol Cell Biol; 2002 Aug; 22(16):5835-45. PubMed ID: 12138194
[TBL] [Abstract][Full Text] [Related]
11. Membrane estrogen receptor-dependent extracellular signal-regulated kinase pathway mediates acute activation of endothelial nitric oxide synthase by estrogen in uterine artery endothelial cells.
Chen DB; Bird IM; Zheng J; Magness RR
Endocrinology; 2004 Jan; 145(1):113-25. PubMed ID: 14512434
[TBL] [Abstract][Full Text] [Related]
12. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.
Atanaskova N; Keshamouni VG; Krueger JS; Schwartz JA; Miller F; Reddy KB
Oncogene; 2002 Jun; 21(25):4000-8. PubMed ID: 12037682
[TBL] [Abstract][Full Text] [Related]
13. Essential role of endogenous prolactin and CDK7 in estrogen-induced upregulation of the prolactin receptor in breast cancer cells.
Kavarthapu R; Dufau ML
Oncotarget; 2017 Apr; 8(16):27353-27363. PubMed ID: 28423697
[TBL] [Abstract][Full Text] [Related]
14. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase.
Kato S; Endoh H; Masuhiro Y; Kitamoto T; Uchiyama S; Sasaki H; Masushige S; Gotoh Y; Nishida E; Kawashima H; Metzger D; Chambon P
Science; 1995 Dec; 270(5241):1491-4. PubMed ID: 7491495
[TBL] [Abstract][Full Text] [Related]
15. MEKK1 activation of human estrogen receptor alpha and stimulation of the agonistic activity of 4-hydroxytamoxifen in endometrial and ovarian cancer cells.
Lee H; Jiang F; Wang Q; Nicosia SV; Yang J; Su B; Bai W
Mol Endocrinol; 2000 Nov; 14(11):1882-96. PubMed ID: 11075819
[TBL] [Abstract][Full Text] [Related]
16. Ligand binding promotes CDK-dependent phosphorylation of ER-alpha on hinge serine 294 but inhibits ligand-independent phosphorylation of serine 305.
Held JM; Britton DJ; Scott GK; Lee EL; Schilling B; Baldwin MA; Gibson BW; Benz CC
Mol Cancer Res; 2012 Aug; 10(8):1120-32. PubMed ID: 22669764
[TBL] [Abstract][Full Text] [Related]
17. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis.
Filardo EJ; Quinn JA; Frackelton AR; Bland KI
Mol Endocrinol; 2002 Jan; 16(1):70-84. PubMed ID: 11773440
[TBL] [Abstract][Full Text] [Related]
18. Human estrogen receptor beta binds DNA in a manner similar to and dimerizes with estrogen receptor alpha.
Pace P; Taylor J; Suntharalingam S; Coombes RC; Ali S
J Biol Chem; 1997 Oct; 272(41):25832-8. PubMed ID: 9325313
[TBL] [Abstract][Full Text] [Related]
19. Palmitoylation regulates 17β-estradiol-induced estrogen receptor-α degradation and transcriptional activity.
La Rosa P; Pesiri V; Leclercq G; Marino M; Acconcia F
Mol Endocrinol; 2012 May; 26(5):762-74. PubMed ID: 22446104
[TBL] [Abstract][Full Text] [Related]
20. Estrogen and pure antiestrogen fulvestrant (ICI 182 780) augment cell-matrigel adhesion of MCF-7 breast cancer cells through a novel G protein coupled estrogen receptor (GPR30)-to-calpain signaling axis.
Chen Y; Li Z; He Y; Shang D; Pan J; Wang H; Chen H; Zhu Z; Wan L; Wang X
Toxicol Appl Pharmacol; 2014 Mar; 275(2):176-81. PubMed ID: 24440569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]